ALP Bio AG

History from 14 Jan 2026

Nominal capital · CHFCHF 131k

SHAB published 19 Jan 2026 · legal date 14 Jan 2026
Company formed
Founded 14 Jan 2026
SHAB HR01-1006541762 ↗
SHAB published 30 Mar 2026 · legal date 20 Mar 2026
Capital increase
Likely financing
Paid in cash
Nominal capital
100’000 → 131’096.20
Shares
1’000’000 → 1’310’962
New shares, % of post-step shares
23.7% (310’962 new)
Share classes
1’000’000 × CHF 0.10 · 310’962 × CHF 0.10 Vorzugsaktien Pre-Seed
Aktienkapital neu: CHF 131'096.20 [bisher: CHF 100'000.00]. Liberierung Aktienkapital neu: CHF 81'096.20 [bisher: CHF 50'000.00]. Aktien neu: 1'000'000 Namenaktien zu CHF 0.10 und 310'962 Namenaktien zu CHF 0.10 (Vorzugsaktien Pre-Seed) [bisher: 1'000'000 Namenaktien zu CHF 0.10].
From the SHAB entry · German original, person names removed · not an official copy · full entry ↗
- The increase is an odd amount in small-nominal shares, as priced rounds usually are.+1.0
- The company was founded less than six years before this capital increase.+0.5
- The company's purpose describes technology or life-sciences development.+0.5
- A new class of preferred shares was created.+1.5
Classifier score 0.96 · likely-financing threshold 0.60 · not a calibrated probability
SHAB HR02-1006609939 ↗

Published by 5 Apr 2026

Record